Prothena Corp. plc buy Chardan Capital
Start price
20.12.24
/
50%
€14.50
Target price
20.12.25
€38.43
Performance (%)
-45.86%
End price
21.12.25
€7.85
Summary
This prediction ended on 21.12.25 with a price of €7.85. The BUY prediction by Chardan_Capital for Prothena Corp. plc performed very badly with a performance of -45.86%. Chardan_Capital has a follow-up prediction for Prothena Corp. plc where he still thinks Prothena Corp. plc is a Buy. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Prothena Corp. plc | -8.025% | -8.025% | -46.786% |
| iShares Core DAX® | -1.020% | 0.271% | 13.941% |
| iShares Nasdaq 100 | -3.122% | -1.929% | 1.920% |
| iShares Nikkei 225® | 0.649% | 6.582% | 21.176% |
| iShares S&P 500 | -0.142% | -0.295% | 1.363% |
Comments by Chardan_Capital for this prediction
In the thread Prothena Corp. plc diskutieren
Prothena Co. plc (NASDAQ: PRTA) is now covered by analysts at Chardan Capital. They set a "buy" rating and a $40.00 price target on the stock.
Ratings data for PRTA provided by MarketBeat
In the thread Trading Prothena Corp. plc
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten

